The Trump administration’s healthcare policy changes from the gutting of medical research grants to changes on the CDC vaccine board were the focus of the discussion on the latest episode of the Debunked Podcast with MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of Health Innovation Pitch.

The post Debunked Episode 17: Is Big Pharma Prepared for Impact of Trump Administration’s Health Policies? appeared first on MedCity News.

[Sponsored] A one-size fits most approach to clinical trial recruitment is no longer effective. A webinar discussion emphasized the need for patient-level data to shape each phase of a drug’s lifecycle, from clinical development to market access.

The post How Can RWD Transform the Patient Journey? appeared first on MedCity News.

[Sponsored] The webinar, scheduled for May 22, will include executives from PurpleLab and feature Genentech Principal Informatics Systems Lead Dr. Ben Freiberg. Register today!

The post Eliminating Blind Spots in the Patient Journey appeared first on MedCity News.

[Sponsored] Gilead Sciences is a leader in the field of virology treatments. As VP of clinical research for hepatitis, respiratory and emerging viruses at Gilead, Anu Osinusi talked about the pharma company’s work in HIV and hepatitis and how her personal background informed her team’s work in developing a Covid-19 treatment.

The post MedCity Pivot Podcast: A conversation with Gilead Sciences VP Anu Osinusi appeared first on MedCity News.

[Sponsored] Improving Customer Experience and Conversion in Healthcare & Life Sciences.

The post Creating an Omnichannel Customer Journey in Healthcare appeared first on MedCity News.

At the upcoming INVEST Digital Health conference in Dallas set for September 28, in collaboration with Health Wildcatters, a panel discussion on the future of pharmacy benefit managers will be part of the larger conversation on employee benefits. AJ Loiacono, CapitalRx CEO, shared his perspective on the topic.

The post 3 ways to reform the pharmacy benefits industry appeared first on MedCity News.

[Sponsored] A panel discussion from a recent Microsoft summit offered insights on how tech companies are closely collaborating with the pharma industry as they seek to repair and improve manufacturing supply chain issues exposed by the Covid-19 pandemic.

The post The power of digital ecosystems to improve pharma supply chain operations appeared first on MedCity News.

[Sponsored] Decentralized clinical trial approaches helped the pharma industry navigate through Covid-19. Now it is becoming increasingly clear that there’s a need for a hybrid approach to decentralized clinical trials that considers the perspectives of patients and the impact to clinical trial sites.

The post Digital transformation: Reimagining clinical trial management appeared first on MedCity News.

[Sponsored] Emergn Principal Consultant Mario Moreira shared insights on how pharma companies can use the principles of Value, Flow and Quality to shorten drug development timelines and deliver better patient outcomes through improved ways of working.

The post How the agile in pharma trend is transforming drug development appeared first on MedCity News.

[Sponsored] “Most Q&As are happening on Twitter. If you’re not doing social listening you’re losing fresh insights into things like disease states.” That was just one of the observations in a new report on how pharma and other life science companies are working with healthcare providers and adapting to improve the patient experience.

The post Medical education through Twitter? Pharma’s digital strategy for healthcare appeared first on MedCity News.

[Sponsored] “Most Q&As are happening on Twitter. If you’re not doing social listening you’re losing fresh insights into things like disease states.” That was just one of the observations in a new report on how pharma and other life science companies are working with healthcare providers and adapting to improve the patient experience.

The post Medical education through Twitter? Pharma’s digital strategy for healthcare providers appeared first on MedCity News.

[Sponsored] A look at how healthcare organizations are collaborating with Microsoft to enhance patient engagement, accelerate healthcare innovation, improve clinical and operational insights, and more.

The post Transforming healthcare in the cloud appeared first on MedCity News.

[Sponsored] Microsoft seeks to change the way pharma industry companies use technology to better navigate human resource and supply chain challenges.

The post The quest to restore confidence in drug development supply chains appeared first on MedCity News.

By engaging in a dialogue, patients and pharma companies can have a mutually beneficial relationship, Health Union’s Jack Barrette said at HLTH’s patient engagement track, hosted by MedCity News. Not only can patients help mold clinical trials, but they can help companies improve their patient education efforts.

The post Joining forces can benefit both patients and pharma companies   appeared first on MedCity News.

[Sponsored] Clinical 2021 is US and EU pharma’s leading event for clinical innovators – join 500+ executive attendees from across the globe to meet and learn virtually.

The post Rebuild clinical trials in the image of patient need. Join Sanofi, Janssen, FDA, Pfizer and more appeared first on MedCity News.

[Sponsored] Did you miss the event? Register for the On-Demand Webinar to learn how digital engagement can solve challenges for both patients and the brand and learn other benefits that will improve patient experience and address multiple barriers to medication adherence.

The post Using digital engagement to solve pain points along the patient journey: How to deliver better outcomes for patients and brands appeared first on MedCity News.

With more readers and greater engagement in our content than ever, we have many products that can help you reach your customer base through our content, ads, podcasts and online events. Contact us to learn more.

The post MedCity News will help you reach clients and raise awareness during Covid-19 appeared first on MedCity News.

Propeller Health and Novartis received the green light from European regulators to package their products together. The move is one step of many to make digital therapeutics easier to prescribe.

The post Propeller gets green light to bundle its digital health tools with inhalers appeared first on MedCity News.

The increased patient-centric focus in drug development by the FDA is highly encouraging and expected to become more mainstream and legislated. 

The post The power of patient voice in clinical trial design appeared first on MedCity News.

IBM is stopping the development and sales of the product, which uses Watson AI to help pharmaceutical companies find new drugs, because it wasn’t yielding large enough financial returns, according to a STAT report.

The post Report: IBM is ending sales of Watson for Drug Discovery appeared first on MedCity News.

As pharma continues to close the gap between the operational and analytical needs of their business, they can look to other industries for best practices.

The post Why pharma is starting to think more like Amazon appeared first on MedCity News.

The behavioral health epidemic, artificial intelligence and more procedures being done in outpatient settings are some the key 2019 trends that will determine how decision makers purchase technology.

The post Five innovation trends that will impact the healthcare industry in 2019 appeared first on MedCity News.

Strategic partnerships are one way for biopharmaceutical companies to expand capabilities and offerings and proactively define their future versus having it defined for them.

The post Biopharma needs a new R&D, innovation model appeared first on MedCity News.

A new survey found chief medical information officers believe medication management improvement initiatives have positively impacted patient safety, but factors like workflow variation and a lack of price transparency still compromise patients’ well-being.

The post What do CMIOs think of medication management initiatives? appeared first on MedCity News.

Panelists highlight Roche’s acquisition of Flatiron Health in February and use of AI/ML in drug development.

The post Pharma is making inroads into digital health, albeit slowly appeared first on MedCity News.

The issue of conflicts of interest has become more pressing in recent years as drug prices soar and healthcare companies reach out to the academic and policy community for advice — often with generous payments attached, ethics experts say.

The post The potential for conflict of interest when health policy experts also serve on the boards of pharma companies appeared first on MedCity News.

It’s the latest in a series of companies Roche has acquired to add services and technology to the Big Pharma’s drug development business, particularly in cancer treatment.

The post Roche acquires the rest of Foundation Medicine for $2.4B, supporting its precision medicine strategy appeared first on MedCity News.

A KHN analysis found that 47 of the drugs cost Medicare and Medicaid almost $12 billion in 2016. The spending totals don’t include rebates, which drugmakers return to the government after paying for the drugs upfront but are not public.

The post FDA: Drugmaker ‘shenanigans’ delaying cheaper competitors and boosting prices appeared first on MedCity News.

A new report shows a steady growth in so-called “basket studies” in oncology, along with growing interest by the drug industry.

The post Drugmakers increasingly target “baskets” of tumors based on mutations appeared first on MedCity News.

In his plans to cut sky-high drug prices unveiled Friday, Trump said that increasing industry competition will help Americans save at the pharmacy counter.

The post Trump’s drug cost cutting plans include transparency, but critics doubt much will change appeared first on MedCity News.